WallStreetZenWallStreetZen

NASDAQ: FDMT
4d Molecular Therapeutics Inc Stock Ownership - Who owns 4d Molecular Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have 4d Molecular Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Scott BizilyChief Legal Officer2024-09-16500$16.33
$8.16kSell
Scott BizilyChief Legal Officer2024-09-16500$6.49
$3.25kBuy
Scott BizilyChief Legal Officer2024-08-19500$6.49
$3.25kBuy
Scott BizilyChief Legal Officer2024-08-19500$15.00
$7.50kSell
Scott BizilyChief Legal Officer2024-07-161,250$8.04
$10.05kBuy
Scott BizilyChief Legal Officer2024-07-16500$6.49
$3.25kBuy
Scott BizilyChief Legal Officer2024-07-161,750$27.11
$47.44kSell
Scott BizilyChief Legal Officer2024-07-111,996$15.78
$31.50kBuy
Scott BizilyChief Legal Officer2024-07-111,996$25.00
$49.90kSell
David KirnChief Executive Officer2024-07-1011,653$14.42
$168.04kBuy

1 of 3

FDMT insiders have bought as... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FDMT insiders and whales buy or sell their stock.

FDMT Shareholders

What type of owners hold 4d Molecular Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc10.63%4,921,321$15.06MInstitution
Ra Capital Management LP9.86%4,563,211$13.96MInstitution
Ra Capital Management LP9.86%4,563,211$13.96MInsider
Goldman Sachs Group Inc9.23%4,274,973$13.08MInstitution
Viking Global Investors LP9.17%4,247,914$13.00MInsider
Vr Adviser LLC6.38%2,952,371$9.03MInstitution
Vanguard Group Inc6.18%2,860,508$8.75MInstitution
Bvf Inc5.77%2,670,642$8.17MInstitution
Janus Henderson Group PLC4.86%2,252,240$6.89MInstitution
Morgan Stanley4.02%1,863,057$5.70MInstitution

1 of 3

FDMT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FDMT78.75%21.25%Net Buying
PBYI55.88%43.77%Net Selling
IKT67.36%24.73%Net Buying
FENC4.45%95.55%Net SellingNet Selling
TARA48.52%51.48%Net SellingNet Selling
View Top Biotech Stocks

4d Molecular Therapeutics Stock Ownership FAQ

Who owns 4d Molecular Therapeutics?

4d Molecular Therapeutics (NASDAQ: FDMT) is owned by 101.21% institutional shareholders, 27.31% 4d Molecular Therapeutics insiders, and 0.00% retail investors. Ra Capital Management LP is the largest individual 4d Molecular Therapeutics shareholder, owning 4.56M shares representing 9.86% of the company. Ra Capital Management LP's 4d Molecular Therapeutics shares are currently valued at $13.96M.

If you're new to stock investing, here's how to buy 4d Molecular Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.